Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is caused by both genetics and environmental factors like diet and obesity.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Ficus carica extract improved fertility in rats and may help with certain health conditions.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Estrogens and progesterone are key in regulating melasma pigmentation.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

Scientists now better understand how human hair growth is controlled, including the roles of specific genes and proteins.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.